Research we are currently funding:
If successful, this study should significantly improve the patient care of those suffering with advanced liver cancer by making drug treatment more effective.
This project will evaluate the impact of improved chronic hepatitis C (HCV) treatment on liver cancer incidence and survival.
Professor George’s team is implementing a hepatitis B community program with the goal of preventing the onset of liver cancer.
Impact we've achieved with our research:
Dr Lionel Hebbard and his team conducted a long-range study that aimed to quantify the exact impact of metabolic drivers, particularly obesity, on liver cancer prognosis and progression in p